Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Novel plant-level data from Germany sheds light on the current status and the potential determinants of robot use in manufacturing factories.
As most countries experience COVID-19 related lockdowns, there are concerns about both the present and the future of global supply chains.
Women’s specific needs and potential as leaders and agents of change must be considered for COVID-19 mitigation and recovery measures.